Drug intelligence / Profile preview

anti-fel-d1 igy

Development stage
Unknown
Lead developer
Nestlé Purina PetCare
Modality
Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
Administration
Oral (as An Ingredient In Cat Food)
01

Overview

Anti-Fel d1 IgY is a preparation of **immunoglobulin Y (IgY) antibodies** derived from the eggs of hens immunized with **Fel d1**, the major cat allergen. These IgY antibodies specifically bind to Fel d1 in the saliva of cats. When incorporated as an ingredient in cat food, anti-Fel d1 IgY binds and neutralizes Fel d1 in the oral cavity, thereby reducing active Fel d1 on the cat's haircoat (spread during grooming) and decreasing environmental allergen load. The mechanism is not direct immunomodulation in cats or humans, but physical blockade of the allergen, preventing it from binding human IgE and triggering allergic reactions. This strategy offers a novel dietary approach to reduce exposure to cat allergen, benefitting individuals allergic to cats.

Other names
chicken egg anti-fel-d1 igyegg-derived anti-fel-d1 igyegg yolk anti-fel-d1 igyavian anti-fel-d1 igy

Beyond the preview

Go deeper on anti-fel-d1 igy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on anti-fel-d1 igy.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call